The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
Open accessAbstract
SUMMARY Inflammation-mediated neurodegeneration occurs in the acute and the chronic phases of multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Classically-activated (M1) microglia are key players mediating this process. Here we identified Galectin-1 (Gal1), an endogenous glycan-binding protein, as a pivotal regulator of M1 microglia activation, targeting the activation of p38MAPK-, CREB-, and NF-κB-dependent signaling pathways and hierarchically supressing downstream pro-inflammatory mediators such as iNOS, TNF and CCL2. Gal1 bound to core 2 O-glycans on CD45, favoring retention of this glycoprotein on the microglial cell surface and augmenting its phosphatase activity and inhibitory function. Gal1 was highly expressed in the acute phase of EAE and its targeted deletion resulted in pronounced inflammation-induced neurodegeneration. Adoptive transfer of Gal1-secreting astrocytes or administration of recombinant Gal1 suppressed EAE through mechanisms involving microglia de-activation. Thus, Gal1-glycan interactions are essential in tempering microglia activation, brain inflammation and neurodegeneration with critical therapeutic implications for MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Storck, T., Schulte, S., Hofmann, K., & Stoffel, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10955 · Cited by 1,183
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Oligosaccharide specificity of galectins: a search by frontal affinity chromatography
Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Oka, T., Futai, M., Muller, W. E. G., et al. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00311-2 · Cited by 926
Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., Martino, G., & Schwartz, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.006 · Cited by 923
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells
Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Karman, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 701
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653
Self-citationGalectin-1: a key effector of regulation mediated by CD4+CD25+ T cells
Garín, M. I., Chu, C.-C., Golshayan, D., Cernuda-Morollón, E., Wait, R., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-04-016451 · Cited by 542
Ilarregui, J. M., Croci, D. O., Bianco, G. A., Toscano, M. A., Salatino, M., Vermeulen, M. E., Geffner, J. R., & Rabinovich, G. A. (2009) · Nature Immunology · doi:10.1038/ni.1772 · Cited by 476
Self-citationType II monocytes modulate T cell–mediated central nervous system autoimmune disease
Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447
Ohtsubo, K., Takamatsu, S., Minowa, M. T., Yoshida, A., Takeuchi, M., & Marth, J. D. (2005) · Cell · doi:10.1016/j.cell.2005.09.041 · Cited by 429
Ponomarev, E. D., Maresz, K., Tan, Y., & Dittel, B. N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-07.2007 · Cited by 396
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Weiner, H. L. (2009) · Annals of Neurology · doi:10.1002/ana.21640 · Cited by 344
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Rabinovich, G. A., & Croci, D. O. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.004 · Cited by 338
Self-citationKang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297
Takeuchi, H., Mizuno, T., Zhang, G., Wang, J., Kawanokuchi, J., Kuno, R., & Suzumura, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413863200 · Cited by 285 · cited 2×
“Because neurotoxicity is closely associated with a collapse of cytoskeleton proteins (Takeuchi et al., 2005), we measured the intensity of immunoreactivity against microtubule-associated protein 2 (Map2), the density of Map2 cells, and the percentage of beaded axons.”
BackgroundStowell, S. R., Qian, Y., Karmakar, S., Koyama, N. S., Dias-Baruffi, M., Leffler, H., McEver, R. P., & Cummings, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3091 · Cited by 255
Production and functions of IL-17 in microglia
Kawanokuchi, J., Shimizu, K., Nitta, A., Yamada, K., Mizuno, T., Takeuchi, H., & Suzumura, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.006 · Cited by 248
van Vliet, S. J., Gringhuis, S. I., Geijtenbeek, T. B. H., & van Kooyk, Y. (2006) · Nature Immunology · doi:10.1038/ni1390 · Cited by 216
Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J. M., Toscano, M. A., Bianco, G. A., Isturiz, M. A., & Rabinovich, G. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.436 · Cited by 206
Self-citationOffner, H., Celnik, B., Bringman, T. S., Casentini-Borocz, D., Nedwin, G. E., & Vandenbark, A. A. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90032-i · Cited by 200
Toscano, M. A., Commodaro, A. G., Ilarregui, J. M., Bianco, G. A., Liberman, A., Serra, H. M., Hirabayashi, J., Rizzo, L. V., & Rabinovich, G. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6323 · Cited by 198
Self-citationGalectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis
Jiang, H.-R., Al Rasebi, Z., Mensah-Brown, E., Shahin, A., Xu, D., Goodyear, C. S., Fukada, S. Y., Liu, F.-T., Liew, F. Y., & Lukic, M. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1167 · Cited by 190
Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK–STAT Pathway
Jeon, S.-B., Yoon, H. J., Chang, C. Y., Koh, H. S., Jeon, S.-H., & Park, E. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000154 · Cited by 178
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans
Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Yoneyama, T., Mori, K., Koie, T., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.215 · Cited by 162
Rasmussen, S., Wang, Y., Kivisäkk, P., Bronson, R. T., Meyer, M., Imitola, J., & Khoury, S. J. (2007) · Brain · doi:10.1093/brain/awm219 · Cited by 154
Self-citationGalectin-3 drives oligodendrocyte differentiation to control myelin integrity and function
Pasquini, L. A., Millet, V, Hoyos, H. C., Giannoni, J. P., Croci, D. O., Marder, M., Liu, F. T., Rabinovich, G. A., & Pasquini, J. M. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.40 · Cited by 152
Self-citationZamvil, S. S., & Steinman, L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00326-x · Cited by 149
N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death
Earl, L. A., Bi, S., & Baum, L. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066191 · Cited by 146
Correa, S. G. (2002) · Glycobiology · doi:10.1093/glycob/cwg010 · Cited by 139
Cedeno‐Laurent, F., Opperman, M. J., Barthel, S. R., Kuchroo, V. K., & Dimitroff, C. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103433 · Cited by 134
Xing, B., Xin, T., Hunter, R. L., & Bing, G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-4 · Cited by 127
Bax, M., García-Vallejo, J. J., Jang‐Lee, J., North, S. J., Gilmartin, T., Hernandez, G. E., Crocker, P. R., Leffler, H., Head, S. R., Haslam, S. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8216 · Cited by 123
Wang, Y., Imitola, J., Rasmussen, S. O., O’Connor, K. C., & Khoury, S. J. (2008) · Annals of Neurology · doi:10.1002/ana.21457 · Cited by 116
Self-citationStrongly enhanced IL-10 production using stable galectin-1 homodimers
van der Leij, J., van den Berg, A., Harms, G., Eschbach, H., Vos, H. J., Zwiers, P. J., van Weeghel, R., Groen, H., Poppema, S., & Visser, L. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.011 · Cited by 111
Inhibitory control of endothelial galectin‐1 on in vitro and in vivo lymphocyte trafficking
Norling, L. V., Sampaio, A. L. F., Cooper, D., & Perretti, M. (2007) · The FASEB Journal · doi:10.1096/fj.07-9268com · Cited by 110
Venkatesan, C., Chrzaszcz, M., Choi, N., & Wainwright, M. S. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-32 · Cited by 107
Zhang, F., Li, Q., Flood, P. M., Shi, J., Hong, J., & Gao, H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165829 · Cited by 95
Walther, M. R., Kuklinski, S., Pesheva, P., Guntinas‐Lichius, O., Angelov, D. N., Neiss, W. F., Asou, H., & Probstmeier, R. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000815)61:4<430::aid-jnr9>3.0.co;2-3 · Cited by 87
Rotshenker, S., Reichert, F., Gitik, M., Haklai, R., Elad‐Sfadia, G., & Kloog, Y. (2008) · Glia · doi:10.1002/glia.20713 · Cited by 85
Cui, Y., Zhang, L., Zhang, T., Luo, D., Jia, Y., Guo, Z., Zhang, Q., Wang, X., & Wang, X. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05314.x · Cited by 81
Plachta, N., Annaheim, C., Bissière, S., Lin, S., Rüegg, M. A., Hoving, S., Müller, D., Poirier, F., Bibel, M., & Barde, Y. (2007) · Nature Neuroscience · doi:10.1038/nn1897 · Cited by 70
Sasaki, T., Hirabayashi, J., Manya, H., Kasai, K.-I., & Endo, T. (2003) · Glycobiology · doi:10.1093/glycob/cwh043 · Cited by 69
Galectin‐4, a novel neuronal regulator of myelination
Stancic, M., Slijepcevic, D., Nomden, A., Vos, M. J., de Jonge, J. C., Sikkema, A. H., Gabius, H., Hoekstra, D., & Baron, W. (2012) · Glia · doi:10.1002/glia.22324 · Cited by 59
Mirzoeva, S., Koppal, T., Petrova, T. V., Lukas, T. J., Watterson, D. M., & Eldik, L. J. V. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01911-3 · Cited by 31
Salemi, J., Obregon, D. F., Cobb, A., Reed, S., Sadic, E., Jin, J., Fernandez, F., Tan, J., & Giunta, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-3 · Cited by 28
Galectin‐4 is involved in p27‐mediated activation of the myelin basic protein promoter
Wei, Q., Eviatar‐Ribak, T., Miskimins, W. K., & Miskimins, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04488.x · Cited by 25
Cited by
Microglial and macrophage polarization—new prospects for brain repair
Hu, X., Leak, R. K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., & Chen, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.207 · Cited by 1,366
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández-Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 650
Chen, A.-Q., Fang, Z., Chen, X.-L., Yang, S., Zhou, Y.-F., Mao, L., Xia, Y.-P., Jin, H.-J., Li, Y.-N., You, M.-F., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1716-9 · Cited by 542
A novel microglial subset plays a key role in myelinogenesis in developing brain
Wlodarczyk, A., Holtman, I. R., Krueger, M., Yogev, N., Bruttger, J., Khorooshi, R., Benmamar‐Badel, A., de Boer‐Bergsma, J. J., Martin, N. A., Karram, K., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696056 · Cited by 535
Neuroinflammation in the central nervous system: Symphony of glial cells
Yang, Q., & Zhou, J. (2019) · Glia · doi:10.1002/glia.23571 · Cited by 519
Metadata
- Authors
- Starossom, S. C., Mascanfroni, I. D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S. F., Bassil, R., Croci, D. O., Cerliani, J. P., Delacour, D., Wang, Y., Elyaman, W., Khoury, S. J., & Rabinovich, G. A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 37
- Issue
- 2
- Pages
- 249-263
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2080432978
- Cited by
- 354
- References
- 51
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.